Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol.
Dameri M, Cirmena G, Ravera F, Ferrando L, Cuccarolo P, Stabile M, Fanelli GN, Nuzzo PV, Calabrese M, Tagliafico A, Ballestrero A, Zoppoli G. Dameri M, et al. Among authors: cirmena g. Crit Rev Oncol Hematol. 2023 May;185:103963. doi: 10.1016/j.critrevonc.2023.103963. Epub 2023 Mar 15. Crit Rev Oncol Hematol. 2023. PMID: 36931614 Free article. Review.
Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Cirmena G, Garuti A, De Mariano M, Coco S, Ferrando L, Isnaldi E, Barbero V, Fregatti P, Del Mastro L, Ferrando F, Gonella R, Garlaschi A, Friedman D, Ballestrero A, Zoppoli G. Cirmena G, et al. J Oncol. 2020 Jan 22;2020:8132507. doi: 10.1155/2020/8132507. eCollection 2020. J Oncol. 2020. PMID: 32377196 Free PMC article.
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Cirmena G, Ferrando L, Ravera F, Garuti A, Dameri M, Gallo M, Barbero V, Ferrando F, Del Mastro L, Garlaschi A, Friedman D, Fregatti P, Ballestrero A, Zoppoli G. Cirmena G, et al. JCO Precis Oncol. 2022 Feb;6:e2100198. doi: 10.1200/PO.21.00198. JCO Precis Oncol. 2022. PMID: 35201850 Free PMC article.
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study.
Ravera F, Borea R, Cirmena G, Dameri M, Ferrando L, Gallo M, Casini C, Fallani N, Stabile M, Barbero V, Murialdo R, Tixi L, Cappuccio M, Cuboni A, Sivieri I, Fornarini G, De Maria A, Ballestrero A, Zoppoli G. Ravera F, et al. Among authors: cirmena g. J Transl Med. 2022 May 14;20(1):230. doi: 10.1186/s12967-022-03429-0. J Transl Med. 2022. PMID: 35568887 Free PMC article.
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions.
Garuti A, Rocco I, Cirmena G, Chiaramondia M, Baccini P, Calabrese M, Palermo C, Friedman D, Zoppoli G, Ballestrero A. Garuti A, et al. Among authors: cirmena g. Gynecol Oncol. 2014 Feb;132(2):389-96. doi: 10.1016/j.ygyno.2013.11.020. Epub 2013 Nov 21. Gynecol Oncol. 2014. PMID: 24269902
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
Isnaldi E, Garuti A, Cirmena G, Scabini S, Rimini E, Ferrando L, Lia M, Murialdo R, Tixi L, Carminati E, Panaro A, Gallo M, Grillo F, Mastracci L, Repetto L, Fiocca R, Romairone E, Zoppoli G, Ballestrero A. Isnaldi E, et al. Among authors: cirmena g. J Transl Med. 2019 Apr 29;17(1):137. doi: 10.1186/s12967-019-1879-2. J Transl Med. 2019. PMID: 31036005 Free PMC article.
38 results